Back to top
more

Abbott Laboratories (ABT)

(Real Time Quote from BATS)

$105.89 USD

105.89
1,068,079

-1.60 (-1.49%)

Updated Jun 11, 2024 11:02 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (90 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

Is Abbott Laboratories (ABT) Stock Outpacing Its Medical Peers This Year?

Here is how Abbott (ABT) and Akoya Biosciences (AKYA) have performed compared to their sector so far this year.

Manufacturing Numbers Expected After Opening Bell

Manufacturing Numbers Expected After Opening Bell.

Abbott's (ABT) Q4 Earnings Match Estimates, Margins Rise

Abbott (ABT) delivers better-than-expected revenues and in-line earnings for the fourth quarter of 2023.

Mark Vickery headshot

Q4 Earnings Roundup: ABT, GD, KMB & More

A spot-check of early morning Q4 reports show some earnings misses and revenue beats; Tesla and others report after the close.

Here's What Key Metrics Tell Us About Abbott (ABT) Q4 Earnings

While the top- and bottom-line numbers for Abbott (ABT) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Abbott (ABT) Q4 Earnings Match Estimates

Abbott (ABT) delivered earnings and revenue surprises of 0% and 0.71%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Shaun Pruitt headshot

Top Stocks to Watch as Earnings Approach

Several expansive companies are expected to post stellar quarterly growth when they report Q4 results on Wednesday, January 24.

What's in Store for Zimmer Biomet (ZBH) in Q4 Earnings?

Zimmer Biomet (ZBH) is expected to have gained from the uptake of Persona OsseoTi Keel Tibia for Cementless Knee Replacement in the fourth quarter.

Should You Buy Abbott Laboratories (ABT) Ahead of Earnings?

Abbott Laboratories (ABT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

CVS Health (CVS) to Report Q4 Earnings: What's in the Cards?

CVS Health's (CVS) fourth-quarter 2023 results are likely to reflect the strength of the Pharmacy & Consumer Wellness and Health Services segments.

Seeking Clues to Abbott (ABT) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

Beyond analysts' top -and-bottom-line estimates for Abbott (ABT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.

If You Invested $1000 in Abbott 10 Years Ago, This Is How Much You'd Have Now

Holding on to popular or trending stocks for the long-term can make your portfolio a winner.

Abbott (ABT) Ascends But Remains Behind Market: Some Facts to Note

Abbott (ABT) concluded the recent trading session at $114.02, signifying a +0.08% move from its prior day's close.

Will Abbott (ABT) Beat Estimates Again in Its Next Earnings Report?

Abbott (ABT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Abbott's (ABT) Innovations Aid, Macroeconomic Issues Stay

Abbott (ABT) is successfully continuing the rollout of Alinity, the company's fully integrated and automated molecular diagnostics analyzer.

What's in Store for Abbott Laboratories (ABT) in Q4 Earnings?

Abbott Laboratories' (ABT) fourth-quarter 2023 results are likely to reflect solid base business momentum.

The Zacks Analyst Blog Highlights Advanced Micro Devices, Abbott Laboratories, Qualcomm, Morgan Stanley and Intuitive Surgical

Advanced Micro Devices, Abbott Laboratories, Qualcomm, Morgan Stanley and Intuitive Surgical are included in this Analyst Blog.

Sheraz Mian headshot

Top Analyst Reports for AMD, Abbott Laboratories & QUALCOMM

Today's Research Daily features new research reports on 16 major stocks, including Advanced Micro Devices, Inc. (AMD), Abbott Laboratories (ABT) and QUALCOMM Incorporated (QCOM).

Abbott (ABT) Rises Higher Than Market: Key Facts

The latest trading day saw Abbott (ABT) settling at $113.92, representing a +0.37% change from its previous close.

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.

Abbott (ABT) Advances While Market Declines: Some Information for Investors

Abbott (ABT) closed at $112.73 in the latest trading session, marking a +0.29% move from the prior day.

Tandem Diabetes (TNDM) and Abbott Debut New Integrated Offering

Tandem Diabetes' (TNDM) t:slim X2 is the first AID system to be integrated with Abbott's Freestyle Libre 2 Plus sensor.

Derek Lewis headshot

3 Dividend Growers Suited for Income Investors

A company's ability to consistently pay and increase dividend payouts reflects a stable and healthy financial position. Who doesn't enjoy payday?

Here's Why Investors Should Retain Abbott (ABT) Stock Now

Investors are optimistic about Abbott (ABT) led by solid prospects in the Diagnostic business and raised guidance.